Testimonials
I worked with Helmut twice in my career. The first time as early as 1995 when Helmut joined the Sandoz plant “Biochemie Kundl” in Austria where he established his first footprint in the development of biosimilars. Our second interaction started 18 years later when I hired Helmut as a consultant for Polpharma’s biologics business. At that time, Polpharma was ready to launch a state-of-the-art bio-manufacturing facility in Gdansk. Helmut’s support was much needed in managing the many scientific and commercial aspects Polpharma had to deal with in Latin America, the Middle East and in Asia. Helmut always proved his ability to be a strong manager who delivered the expected results. He combines excellent planning and organizational skills with good analytic thinking. Helmut is a powerful, honest and fair partner in any pharma project.
Hannes Teissl, Chief Business Officer, Polpharma Biologics, Poland
Helmut worked with USV Biologics since his time at Kwizda Pharma. Following his visit to our biologics manufacturing site in Mumbai, we continued to maintain the contact with him and finally hired him as a consultant for our biosimilar program. Subsequently, he accompanied our team with the goal to identify suitable Clinical Research Organizations in the United Kingdom, Germany, Hungary and Austria. In addition, Helmut significantly added business intelligence as to marketing strategies, pricing and regulatory processes of biosimilars in Europe. His management summaries are unsurpassed and with his competent consultancy advice, Helmut always delivered a reliable basis for USV’s management decisions regarding our biosimilar program. We can highly recommend Helmut as a consultant in the biosimilar field.
Dr. Esmail Samiwala, Senior Vice President, Biologics. USV Biologics, India
This reference highlights the pivotal role of Helmut Brunar and his team in our collaborations, where their expertise in conducting thorough due diligence on pharma assets has been instrumental in guiding our investment decisions. Helmut’s approach is comprehensive and versatile. He is adept at analyzing technologies, assessing potential markets, and critically evaluating business plans. His skill in simplifying complex technical details for our management team has been invaluable. Additionally, his proactive efforts to ensure alignment with industry standards have safeguarded our fund from potentially unsatisfactory investments. Based on our experiences, we confidently recommend Helmut and the team at PassionBio for their exceptional ability in navigating complex investment decisions within the pharma sector.
Ultra-High-Net-Worth Individual and Owner of MGFO Private Investments
